Net Income

Trasteel Holding S.A. agrees to a $1.3B merger with Sizzle Acquisition Corp. II, aiming for a Nasdaq listing amid a challenging global steel market.

Nutraville's new brain supplement CogniSurge touts a 'glycocalyx' fix. We examine the science, the sales pitch, and what consumers should know.

Red White & Bloom scoops up insolvent rival Ayurcann's assets, betting big on high-growth vape and pre-roll brands to dominate Canada's market.

S. S. Rajamouli's IMAX epic 'Varanasi' partners with SkyBlue Cinematix, pioneering a new era of brand storytelling beyond simple product placement.

The Vermont ski maker's new certification signals a shift from carbon neutrality to verified climate action. Can performance and planet truly coexist?

FB Financial posts impressive Q1 earnings with major gains in loans and deposits, all while being named #1 in customer satisfaction and trust by J.D. Power.

Orla Mining reports robust Q1 output and secures a key permit in Mexico, keeping it on track for its 2026 guidance and fueling its growth pipeline.

Net Power appoints project finance expert Lee Shuman as CFO, signaling a major push to commercialize its clean gas power plants amid high market demand.

How one California school district modernized its campuses and trained students for green jobs—all without burdening taxpayers. Here's the financial blueprint.

Energy veteran Scott McNeill joins Infinity's board, bringing a track record of billion-dollar deals and operational scaling to the Appalachian producer.

The Alaska Native corporation's spring distribution highlights a unique model where financial success directly fuels cultural vitality and environmental restoration.

As Woodward prepares its Q2 earnings call, investors watch to see if record-breaking aerospace and industrial growth can overcome market headwinds.

As community health centers face burnout and financial strain, one firm says AI and automation can streamline operations and refocus teams on patient care.

AriseAlpha's new app promises easy crypto returns, replacing costly mining rigs. But can automated bots truly outsmart the market's notorious volatility?

A new once-daily pill for hypoparathyroidism begins human testing, promising to replace burdensome injections and transform patient care. Is this the future?

With shareholder approval secured, Montage Gold is one step away from acquiring African Gold, a move set to create a new powerhouse in West Africa's gold sector.

With new funding, ImageneBio advances its unique OX40 inhibitor, IMG-007, for eczema and alopecia, but faces a divided Wall Street.

ANI Pharmaceuticals launches a generic version of Carbatrol, aiming for a slice of a $65M market and promising improved patient access for chronic conditions.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.

A new coalition aims to bring cheaper, cleaner power to Arkansas, but must navigate rising demand, local opposition, and complex regulatory challenges.